Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Expression Analysis Signs Lab Ops VP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Expression Analysis Signs Lab Ops VP

Genzyme vet joins executive management team

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Tyler Aldredge has been named vice president of Laboratory Operations at Expression Analysis, a provider of genetic and genomic testing and analysis for the pharmaceutical and biotechnology industries. Mr. Aldredge has genomics experience in both clinical and research laboratories. Most recently, he held the position of director of Laboratory Operations at Genzyme Genetics, a clinical laboratory that provides a variety of genetic and specialty laboratory tests to physicians worldwide. Prior to that, he was employed by the Broad Institute, Harvard University Center for Genomic Research, Sanofi, Codon Devices and Genome Therapeutics Corp.

“Tyler’s background in engineering, laboratory operations and genomics makes him an ideal candidate to lead our world class operations team at EA,” says Steve McPhail, chief executive officer and President of EA. “Tyler possesses the necessary skill set to lead EA as it continues to grow and expand its service offerings; he will add tremendous benefit to our clients and have a positive impact on our operations, culture and future growth strategies.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics